Boothbay Fund Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.37M Buy
10,922
+9,112
+503% +$1.14M 0.03% 446
2025
Q1
$248K Buy
+1,810
New +$248K 0.01% 947
2023
Q1
Sell
-850
Closed -$235K 1880
2022
Q4
$235K Sell
850
-1,077
-56% -$298K 0.01% 1301
2022
Q3
$515K Sell
1,927
-18,225
-90% -$4.87M 0.01% 1053
2022
Q2
$4.11M Buy
20,152
+2
+0% +$408 0.11% 219
2022
Q1
$4.24M Sell
20,150
-3,217
-14% -$678K 0.1% 209
2021
Q4
$5.61M Buy
23,367
+13,079
+127% +$3.14M 0.13% 133
2021
Q3
$2.91M Sell
10,288
-9,233
-47% -$2.61M 0.08% 241
2021
Q2
$6.76M Buy
19,521
+17,741
+997% +$6.14M 0.22% 76
2021
Q1
$498K Sell
1,780
-700
-28% -$196K 0.02% 769
2020
Q4
$607K Buy
2,480
+1,333
+116% +$326K 0.02% 556
2020
Q3
$325K Sell
1,147
-4,166
-78% -$1.18M 0.02% 673
2020
Q2
$1.42M Sell
5,313
-906
-15% -$242K 0.1% 232
2020
Q1
$1.97M Sell
6,219
-781
-11% -$247K 0.16% 133
2019
Q4
$2.08M Sell
7,000
-1,085
-13% -$322K 0.18% 129
2019
Q3
$1.88M Buy
8,085
+877
+12% +$204K 0.17% 131
2019
Q2
$1.69M Sell
7,208
-7,679
-52% -$1.8M 0.15% 129
2019
Q1
$3.52M Buy
+14,887
New +$3.52M 0.34% 43
2018
Q4
Hold
0
593
2017
Q1
Sell
-1,847
Closed -$524 657
2016
Q4
$524 Buy
1,847
+241
+15% +$68 0.12% 176
2016
Q3
$503K Sell
1,606
-25,632
-94% -$8.03M 0.11% 166
2016
Q2
$912K Buy
+27,238
New +$912K 0.35% 55